-transparent.png){kind=logo}
Gallium-67 imaging is useful in the management of patients with malignant lymphoma, despite its obvious limitations. Data currently in the literature regarding the detectability of sites of lymphoma by 67Ga imaging should be regarded as representing the minimum that can be expected from the method, since all reported series are based on outmoded imaging techniques. The detectability of disease sites appears to vary with tumor histology and anatomic location. Gallium-67 imaging is most useful in following patients after treatment. However, it may justifiably play an important role in the initial staging of lymphoma if the prior probability of disease in the abdomen is low. Lymphoma in abdominal lymph node sites is at least as detectable by 67Ga imaging as by lymphangiography.
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
December 1978,
Australasian radiology,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
January 1977,
Oncology,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
October 1970,
California medicine,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
May 1972,
Ugeskrift for laeger,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
August 1999,
Cancer biotherapy & radiopharmaceuticals,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
January 1973,
The Journal of nuclear biology and medicine,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
August 1966,
Cancer,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
May 1968,
Postgraduate medicine,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
May 1961,
The Journal-lancet,
D A Turner, and
E W Fordham, and
A Ali, and
R E Slayton
June 1973,
Journal of surgical oncology,
